G1-specific transcriptional repressor WHI5 | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Organism | |||||||
Symbol | WHI5 | ||||||
Entrez | 854249 | ||||||
RefSeq (Prot) | NP_014726.1 | ||||||
UniProt | Q12416 | ||||||
Other data | |||||||
Chromosome | XV: 0.48 - 0.48 Mb | ||||||
|
Whi5 is a transcriptional regulator in the budding yeast, notably in the G1 phase. [1] It plays an important role in cell size control in G1 phase, similarly with Retinoblastoma (Rb) protein in human, although the two have no similarity in sequence [2] Whi5 is an inhibitor of SBF (SCB binding factor), which is involved in the transcription of G1-specific genes. Cln3 promotes the disassociation of Whi5 from SBF, and its disassociation results in the transcription of genes needed to enter S phase. [3]
Whi5 plays an important role in the start checkpoint (G1/S checkpoint), which would have an all-or-non response that allow cells into G1 phase, if only internal conditions and external environments are suitable to enter the cell cycle. For example, if the cell is starving, or there is nutrient depletion, it will halt progressing into the cell cycle and enter G0 phase. Once the start checkpoint (G1/S checkpoint) is satisfied, the cell would enter S phase and initiate DNA replication. Specifically, Whi5 would inhibit SBF in early G1 and therefore inhibit the synthesis of Cln1 and Cln2. In late G1, Whi5 activity is inhibited by Cln1/2-Cdk phosphorylation, thus release the inhibition of SBF and downstream genes. [4]
SBFs (SCB binding factors) are transcription factors that bind to SCB promoter regions, which control the expression of G1-specific proteins, and signal the transition from G1 to S phase. [1] SBF are heterodimers, which contain a DNA-binding unit (Swi4) and a regulatory sub-unit (Swi6). [3] Therefore, activation of SBF will result in the transcription of G1-specific genes. Hypo-phosphorylated Whi5 is stably bound to the SCB promoters via SBF in early G1 phase and suppresses downstream transcription. In the late G1 phase, Whi5 would be hyper-phosphorylated by Cln1/2-Cdk complex, resulting in the dissociation of Whi5 with SBF and exporting Whi5 from the nuclease, [4] releasing the transcriptional inhibition and progressing into G1/S transition.
Once Whi5 is dissociated from SBF-controlled genes, it would result in the transcription of a variety of cell-cycle related genes that allow the cell to enter S phase. These genes include G1/S and S cyclins, which are crucial for the onset of the S phase. [1] SBF-controlled genes are also important for budding and for membrane and cell-wall biosynthesis. Therefore, Whi5 is an important regulator for eventual cell cycle events. [5]
Whi5 contains a total of 19 phosphorylation, with seven sites contributing to hypo-phosphorylation during the early G1 phase, [4] and four sites facilitate the release of Whi5 the SBF complex upon phosphorylation, thus activating G1/S transition. [6]
Cln1/2-Cdk1 promotes the dissociation of Whi5 from SBF through inhibitory hyperphosphorylation. [4] Cdc28 CDK is also believed to involve in this process, [3] which is activated by Cln1, Cln2, and Cln3. Once activated, the association of Whi5 and its dissociation from SBF would result in G1/S transition. Similar with the Rb protein, Whi5 is phosphorylated in various sites during G1, but only certain phosphor-residues would facilitate the transition from G1 to S phase. [3]
Additionally, de Bruin explains that Whi5 phosphorylation determines the timing of SBF-dependent transcriptional activation and cell cycle progression. For example, in a cln3Δ and whi5Δ mutant, cells will enter S phase sooner, because the absence of whi5 bypasses the need for Cln3 activation. Therefore, in a cln3Δ and whi5Δ cell, the timing of cell cycle progression is not regulated by inhibitory phosphorylation by Cln3/Cdk1 and other cyclins, which results in smaller cell size. Thus, Cln3/Cdk1 is important for the dissociation of Whi5 and the timing of when it should dissociate. [3] Whi5 alone cannot determine the correct timing for cell cycle events, but it does affect the onset to begin the transition. [7]
Whi5 would also change its localization depending on phosphorylation levels. [7] In late G1 phase, when Cln1/2-CDK is activated and phosphorylates the CDK-dependent site on Whi5, it not only induces the dissociation of Whi5 from SBF, but also facilitates the export of Whi5 from the nucleus. [4] Whi5 would re-enter in the nucleus in late mitosis, when CDK activity is reduced and CDK-dependent sites on Whi5 become unphosphorylated.
Cell growth is a factor that triggers G1/S transition. One of the molecular mechanisms that can regulate cell growth is the dilution of specific cell cycle regulators, whose amount would remain constant as cell volume increases. [2] Whi5 regulates cell size by its dilution: the amount of Whi5 is nearly constant within G1 phase as cell increases its volume. [8] One of the Whi5 inhibitors, Cln3, would remain constant in concentration when cell growth, which would release the inhibition of downstream genes when Whi5 concentration reaches below the inhibition threshold.
Additionally, Whi5 is synthesized in a size-dependent manner in S/G2/M phases: when daughter cells are born, the small cell tends to have a high concentration of Whi5, which keeps the cell in early G1 phase. As the cell size increases, the preliminary Whi5 amount will be diluted in the larger cytosol volume, and the constant Cln3 concentration will be greater than the concentration of the Whi5 inhibitor. Therefore, the concentration of Whi5 and Cln3 can explain why there are timing standards for when the cell will enter S phase. [8] Thus, the Whi5 inhibitor and its coordination with Cln3 are critical proteins that control cell size.
Despite having no sequence similarity and structral homology, Whi5 and Rb protein still share a variety of similar functions. [9] The most significant similarity should be their roles in the G1 size control. Both Whi5 and Rb protein act as an inhibitor in G1/S transition. The amount of both protein would be diluted by cell growth as G1 progresses, which would in turn trigger G1/S transition after reaching the inhibition threshold. [2] [8]
The two protein also share a similarity in the progression of phosphorylation. Both Whi5 and Rb would initially maintain a low phosphorylation level during early G1 (for Rb it would be initially mono-phosphorylated as reported; [10] for Whi5, it would be hypo-phosphorylated). After G1 commitment, Cdk activity increases and both protein would be hyper-phosphorylated [4] [10] and release their inhibition.
The cell cycle, or cell-division cycle, is the sequential series of events that take place in a cell that causes it to divide into two daughter cells. These events include the growth of the cell, duplication of its DNA and some of its organelles, and subsequently the partitioning of its cytoplasm, chromosomes and other components into two daughter cells in a process called cell division.
Cyclin-dependent kinases (CDKs) are a predominant group of serine/threonine protein kinases involved in the regulation of the cell cycle and its progression, ensuring the integrity and functionality of cellular machinery. These regulatory enzymes play a crucial role in the regulation of eukaryotic cell cycle and transcription, as well as DNA repair, metabolism, and epigenetic regulation, in response to several extracellular and intracellular signals. They are present in all known eukaryotes, and their regulatory function in the cell cycle has been evolutionarily conserved. The catalytic activities of CDKs are regulated by interactions with CDK inhibitors (CKIs) and regulatory subunits known as cyclins. Cyclins have no enzymatic activity themselves, but they become active once they bind to CDKs. Without cyclin, CDK is less active than in the cyclin-CDK heterodimer complex. CDKs phosphorylate proteins on serine (S) or threonine (T) residues. The specificity of CDKs for their substrates is defined by the S/T-P-X-K/R sequence, where S/T is the phosphorylation site, P is proline, X is any amino acid, and the sequence ends with lysine (K) or arginine (R). This motif ensures CDKs accurately target and modify proteins, crucial for regulating cell cycle and other functions. Deregulation of the CDK activity is linked to various pathologies, including cancer, neurodegenerative diseases, and stroke.
A cyclin-dependent kinase complex is a protein complex formed by the association of an inactive catalytic subunit of a protein kinase, cyclin-dependent kinase (CDK), with a regulatory subunit, cyclin. Once cyclin-dependent kinases bind to cyclin, the formed complex is in an activated state. Substrate specificity of the activated complex is mainly established by the associated cyclin within the complex. Activity of CDKCs is controlled by phosphorylation of target proteins, as well as binding of inhibitory proteins.
S phase (Synthesis phase) is the phase of the cell cycle in which DNA is replicated, occurring between G1 phase and G2 phase. Since accurate duplication of the genome is critical to successful cell division, the processes that occur during S-phase are tightly regulated and widely conserved.
The restriction point (R), also known as the Start or G1/S checkpoint, is a cell cycle checkpoint in the G1 phase of the animal cell cycle at which the cell becomes "committed" to the cell cycle, and after which extracellular signals are no longer required to stimulate proliferation. The defining biochemical feature of the restriction point is the activation of G1/S- and S-phase cyclin-CDK complexes, which in turn phosphorylate proteins that initiate DNA replication, centrosome duplication, and other early cell cycle events. It is one of three main cell cycle checkpoints, the other two being the G2-M DNA damage checkpoint and the spindle checkpoint.
Cell cycle checkpoints are control mechanisms in the eukaryotic cell cycle which ensure its proper progression. Each checkpoint serves as a potential termination point along the cell cycle, during which the conditions of the cell are assessed, with progression through the various phases of the cell cycle occurring only when favorable conditions are met. There are many checkpoints in the cell cycle, but the three major ones are: the G1 checkpoint, also known as the Start or restriction checkpoint or Major Checkpoint; the G2/M checkpoint; and the metaphase-to-anaphase transition, also known as the spindle checkpoint. Progression through these checkpoints is largely determined by the activation of cyclin-dependent kinases by regulatory protein subunits called cyclins, different forms of which are produced at each stage of the cell cycle to control the specific events that occur therein.
The G1/S transition is a stage in the cell cycle at the boundary between the G1 phase, in which the cell grows, and the S phase, during which DNA is replicated. It is governed by cell cycle checkpoints to ensure cell cycle integrity and the subsequent S phase can pause in response to improperly or partially replicated DNA. During this transition the cell makes decisions to become quiescent, differentiate, make DNA repairs, or proliferate based on environmental cues and molecular signaling inputs. The G1/S transition occurs late in G1 and the absence or improper application of this highly regulated checkpoint can lead to cellular transformation and disease states such as cancer.
Cyclin A is a member of the cyclin family, a group of proteins that function in regulating progression through the cell cycle. The stages that a cell passes through that culminate in its division and replication are collectively known as the cell cycle Since the successful division and replication of a cell is essential for its survival, the cell cycle is tightly regulated by several components to ensure the efficient and error-free progression through the cell cycle. One such regulatory component is cyclin A which plays a role in the regulation of two different cell cycle stages.
Cyclin D is a member of the cyclin protein family that is involved in regulating cell cycle progression. The synthesis of cyclin D is initiated during G1 and drives the G1/S phase transition. Cyclin D protein is anywhere from 155 to 477 amino acids in length.
Cyclin-dependent kinase 2, also known as cell division protein kinase 2, or Cdk2, is an enzyme that in humans is encoded by the CDK2 gene. The protein encoded by this gene is a member of the cyclin-dependent kinase family of Ser/Thr protein kinases. This protein kinase is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, also known as Cdk1 in humans. It is a catalytic subunit of the cyclin-dependent kinase complex, whose activity is restricted to the G1-S phase of the cell cycle, where cells make proteins necessary for mitosis and replicate their DNA. This protein associates with and is regulated by the regulatory subunits of the complex including cyclin E or A. Cyclin E binds G1 phase Cdk2, which is required for the transition from G1 to S phase while binding with Cyclin A is required to progress through the S phase. Its activity is also regulated by phosphorylation. Multiple alternatively spliced variants and multiple transcription initiation sites of this gene have been reported. The role of this protein in G1-S transition has been recently questioned as cells lacking Cdk2 are reported to have no problem during this transition.
Cyclin-dependent kinase 4 (CDK4), also known as cell division protein kinase 4, is an enzyme that is encoded by the CDK4 gene in humans. CDK4 is a member of the cyclin-dependent kinase family, a group of serine/threonine kinases which regulate the cell cycle. CDK4 regulates the G1/S transition by contributing to the phosphorylation of retinoblastoma (RB) protein, which leads to the release of protein factors like E2F1 that promote S-phase progression. It is regulated by cyclins like cyclin D proteins, regulatory kinases, and cyclin kinase inhibitors (CKIs). Dysregulation of the CDK4 pathway is common in many cancers, and CDK4 is a new therapeutic target in cancer treatment.
Cell division protein kinase 6 (CDK6) is an enzyme encoded by the CDK6 gene. It is regulated by cyclins, more specifically by Cyclin D proteins and Cyclin-dependent kinase inhibitor proteins. The protein encoded by this gene is a member of the cyclin-dependent kinase, (CDK) family, which includes CDK4. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression in the point of regulation named R or restriction point.
Cyclin-dependent kinase 1 also known as CDK1 or cell division cycle protein 2 homolog is a highly conserved protein that functions as a serine/threonine protein kinase, and is a key player in cell cycle regulation. It has been highly studied in the budding yeast S. cerevisiae, and the fission yeast S. pombe, where it is encoded by genes cdc28 and cdc2, respectively. With its cyclin partners, Cdk1 forms complexes that phosphorylate a variety of target substrates ; phosphorylation of these proteins leads to cell cycle progression.
G1/S-specific cyclin Cln3 is a protein that is encoded by the CLN3 gene. The Cln3 protein is a budding yeast G1 cyclin that controls the timing of Start, the point of commitment to a mitotic cell cycle. It is an upstream regulator of the other G1 cyclins, and it is thought to be the key regulator linking cell growth to cell cycle progression. It is a 65 kD, unstable protein; like other cyclins, it functions by binding and activating cyclin-dependent kinase (CDK).
Sic1, a protein, is a stoichiometric inhibitor of Cdk1-Clb complexes in the budding yeast Saccharomyces cerevisiae. Because B-type cyclin-Cdk1 complexes are the drivers of S-phase initiation, Sic1 prevents premature S-phase entry. Multisite phosphorylation of Sic1 is thought to time Sic1 ubiquitination and destruction, and by extension, the timing of S-phase entry.
A series of biochemical switches control transitions between and within the various phases of the cell cycle. The cell cycle is a series of complex, ordered, sequential events that control how a single cell divides into two cells, and involves several different phases. The phases include the G1 and G2 phases, DNA replication or S phase, and the actual process of cell division, mitosis or M phase. During the M phase, the chromosomes separate and cytokinesis occurs.
The Start point is a major cell cycle checkpoint in yeast, known as the restriction point in multicellular organisms. The Start checkpoint ensures cell-cycle entry even if conditions later become unfavorable. The physiological factors that control passage through the Start checkpoint include external nutrient concentrations, presence of mating factor/ pheromone, forms of stress, and size control.
The retinoblastoma protein is a tumor suppressor protein that is dysfunctional in several major cancers. One function of pRb is to prevent excessive cell growth by inhibiting cell cycle progression until a cell is ready to divide. When the cell is ready to divide, pRb is phosphorylated, inactivating it, and the cell cycle is allowed to progress. It is also a recruiter of several chromatin remodeling enzymes such as methylases and acetylases.
BCK2, also named CTR7, is an early cell cycle regulator expressed by the yeast Saccharomyces cerevisiae. It was first discovered in a screen for genes whose overexpression would suppress the phenotypes of PKC1 pathway mutations. Though its mechanism is currently unknown, it is believed to interact with Swi4 and Mcm1, both important transcriptional regulators of early cell cycle.
The Cyclin E/Cdk2 complex is a structure composed of two proteins, cyclin E and cyclin-dependent kinase 2 (Cdk2). Similar to other cyclin/Cdk complexes, the cyclin E/Cdk2 dimer plays a crucial role in regulating the cell cycle, with this specific complex peaking in activity during the G1/S transition. Once the cyclin and Cdk subunits join together, the complex gets activated, allowing it to phosphorylate and bind to downstream proteins to ultimately promote cell cycle progression. Although cyclin E can bind to other Cdk proteins, its primary binding partner is Cdk2, and the majority of cyclin E activity occurs when it exists as the cyclin E/Cdk2 complex.